Ameriprise’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-11,440
| Closed | -$35.4K | – | 4052 |
|
|
2025
Q2 | $35.4K | Sell |
11,440
-7,361
| -39% | -$24.4K | ﹤0.01% | 3927 |
|
|
2025
Q1 | $65.6K | Sell |
18,801
-116
| -0.6% | -$387 | ﹤0.01% | 3922 |
|
|
2024
Q4 | $61.9K | Buy |
+18,917
| New | +$69.6K | ﹤0.01% | 3992 |
|
|
2023
Q4 | – | Sell |
-98,000
| Closed | -$199K | – | 3895 |
|
|
2023
Q3 | $199K | Hold |
98,000
| – | – | ﹤0.01% | 3707 |
|
|
2023
Q2 | $225K | Sell |
98,000
-1,100
| -1% | -$2.86K | ﹤0.01% | 3699 |
|
|
2023
Q1 | $300K | Buy |
99,100
+6,100
| +7% | +$17.2K | ﹤0.01% | 3613 |
|
|
2022
Q4 | $217K | Sell |
93,000
-43,300
| -32% | -$104K | ﹤0.01% | 3685 |
|
|
2022
Q3 | $260K | Buy |
136,300
+29,300
| +27% | +$69K | ﹤0.01% | 3630 |
|
|
2022
Q2 | $290K | Sell |
107,000
-1,907
| -2% | -$4.88K | ﹤0.01% | 3569 |
|
|
2022
Q1 | $324K | Buy |
108,907
+3,521
| +3% | +$10.8K | ﹤0.01% | 3616 |
|
|
2021
Q4 | $410K | Buy |
105,386
+40,825
| +63% | +$159K | ﹤0.01% | 3580 |
|
|
2021
Q3 | $277K | Sell |
64,561
-1,060
| -2% | -$3.53K | ﹤0.01% | 3602 |
|
|
2021
Q2 | $199K | Sell |
65,621
-91,407
| -58% | -$283K | ﹤0.01% | 3754 |
|
|
2021
Q1 | $523K | Sell |
157,028
-480,264
| -75% | -$1.85M | ﹤0.01% | 3385 |
|
|
2020
Q4 | $2.26M | Sell |
637,292
-18,207
| -3% | -$63.7K | ﹤0.01% | 2727 |
|
|
2020
Q3 | $2.05M | Buy |
+655,499
| New | +$1.99M | ﹤0.01% | 2653 |
|
|
2018
Q4 | – | Sell |
-104,506
| Closed | -$987K | – | 3643 |
|
|
2018
Q3 | $987K | Buy |
+104,506
| New | +$1.04M | ﹤0.01% | 3081 |
|
|
2017
Q3 | – | Sell |
-13,349
| Closed | -$48K | – | 3666 |
|
|
2017
Q2 | $48K | Sell |
13,349
-41,609
| -76% | -$143K | ﹤0.01% | 3687 |
|
|
2017
Q1 | $179K | Sell |
54,958
-1,370
| -2% | -$3.8K | ﹤0.01% | 3490 |
|
|
2016
Q4 | $138K | Sell |
56,328
-9,153
| -14% | -$26.6K | ﹤0.01% | 3733 |
|
|
2016
Q3 | $225K | Sell |
65,481
-1,196
| -2% | -$4.67K | ﹤0.01% | 3529 |
|
|
2016
Q2 | $232K | Sell |
66,677
-794
| -1% | -$3.36K | ﹤0.01% | 3492 |
|
|
2016
Q1 | $279K | Sell |
67,471
-562
| -0.8% | -$2.01K | ﹤0.01% | 3398 |
|
|
2015
Q4 | $303K | Buy |
68,033
+39,492
| +138% | +$216K | ﹤0.01% | 3482 |
|
|
2015
Q3 | $174K | Sell |
28,541
-40,030
| -58% | -$355K | ﹤0.01% | 3673 |
|
|
2015
Q2 | $813K | Buy |
68,571
+3,331
| +5% | +$50.7K | ﹤0.01% | 3217 |
|
|
2015
Q1 | $1.14M | Buy |
+65,240
| New | +$1.34M | ﹤0.01% | 2873 |
|
|
2014
Q2 | – | Sell |
-95,914
| Closed | -$2.06M | – | 5575 |
|
|
2014
Q1 | $2.06M | Buy |
+95,914
| New | +$1.72M | ﹤0.01% | 2478 |
|
Other funds holding ABUS
WCM
TSC
ACM
